NO20012984D0 - Succinoylamino benzodiazepiner som inhibitorer av AB proteinproduksjon - Google Patents
Succinoylamino benzodiazepiner som inhibitorer av AB proteinproduksjonInfo
- Publication number
- NO20012984D0 NO20012984D0 NO20012984A NO20012984A NO20012984D0 NO 20012984 D0 NO20012984 D0 NO 20012984D0 NO 20012984 A NO20012984 A NO 20012984A NO 20012984 A NO20012984 A NO 20012984A NO 20012984 D0 NO20012984 D0 NO 20012984D0
- Authority
- NO
- Norway
- Prior art keywords
- succinoylamino
- benzodiazepines
- inhibitors
- protein production
- protein
- Prior art date
Links
- 229940049706 benzodiazepine Drugs 0.000 title 1
- 150000001557 benzodiazepines Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000014616 translation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11358898P | 1998-12-24 | 1998-12-24 | |
| PCT/US1999/030815 WO2000038618A2 (en) | 1998-12-24 | 1999-12-23 | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012984L NO20012984L (no) | 2001-06-15 |
| NO20012984D0 true NO20012984D0 (no) | 2001-06-15 |
Family
ID=22350336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012984A NO20012984D0 (no) | 1998-12-24 | 2001-06-15 | Succinoylamino benzodiazepiner som inhibitorer av AB proteinproduksjon |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US7053084B1 (no) |
| EP (1) | EP1313426A4 (no) |
| JP (1) | JP4615727B2 (no) |
| CN (1) | CN1636011A (no) |
| AU (1) | AU778005B2 (no) |
| BR (1) | BR9917082A (no) |
| CA (1) | CA2347671A1 (no) |
| IL (1) | IL142816A0 (no) |
| NO (1) | NO20012984D0 (no) |
| WO (1) | WO2000038618A2 (no) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
| CN1636011A (zh) | 1998-12-24 | 2005-07-06 | 杜邦药品公司 | 作为Aβ蛋白产生抑制剂的琥珀酰氨基苯并二氮杂䓬 |
| US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
| US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
| MXPA02001813A (es) | 1999-09-13 | 2004-03-19 | Bristol Myers Squibb Pharma Co | Hidroxialcanoilaminolactamas y estructuras relacionas como inhibidores de la produccion de la proteina abeta. |
| EP1218377A1 (en) | 1999-10-08 | 2002-07-03 | Bristol-Myers Squibb Pharma Company | AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| AU2001239791A1 (en) * | 2000-02-17 | 2001-08-27 | Du Pont Pharmaceuticals Company | Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production |
| JP2004508289A (ja) | 2000-04-03 | 2004-03-18 | デュポン ファーマシューティカルズ カンパニー | Ａβタンパク質産生の阻害剤としての環状ラクタム |
| AU2001253090A1 (en) | 2000-04-03 | 2001-10-15 | Bristol-Myers Squibb Pharma Company | Cyclic lactams as inhibitors of abeta protein production |
| JP2004500419A (ja) | 2000-04-11 | 2004-01-08 | デュポン ファーマシューティカルズ カンパニー | Ａβタンパク質産生阻害剤としての置換ラクタム |
| AU2001261728A1 (en) | 2000-05-17 | 2001-11-26 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands for diagnostic imaging |
| GB0012671D0 (en) * | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| AU783857B2 (en) | 2000-06-01 | 2005-12-15 | Bristol-Myers Squibb Pharma Company | Lactams substituted by cyclic succinates as inhibitors of a beta protein production |
| GB0025173D0 (en) * | 2000-10-13 | 2000-11-29 | Merck Sharp & Dohme | Therapeutic agents |
| DE10101430B4 (de) | 2001-01-13 | 2008-10-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Lösliche cyclische Analoga zur Modulation der Amyloidogenese |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| WO2003094854A2 (en) | 2002-05-07 | 2003-11-20 | Elan Pharmaceuticals, Inc. | Succinoyl aminopyrazoles and related compounds |
| US7001901B2 (en) | 2002-08-27 | 2006-02-21 | Bristol-Myers Squibb Company | Tetrazolylpropionamides as inhibitors of Aβ protein production |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| KR100765027B1 (ko) | 2002-12-20 | 2007-10-09 | 글락소 그룹 리미티드 | 신경 장애 치료용 벤즈아제핀 유도체 |
| JP2007516404A (ja) | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ， インコーポレイテッド | 光学点火されたかまたは電気点火された内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット |
| US7759382B2 (en) | 2003-06-05 | 2010-07-20 | Elan Pharmaceuticals, Inc. | Acylated amino acid amidyl pyrazoles and related compounds |
| DK1673347T3 (en) * | 2003-10-06 | 2015-10-12 | Hoffmann La Roche | SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USED AS GAMMA SECRETASE INHIBITORS |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| EP2246086A3 (en) | 2004-08-12 | 2012-11-21 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heating unit |
| EA019115B1 (ru) | 2005-07-15 | 2014-01-30 | Олбани Молекьюлар Рисерч, Инк. | Арил- и гетероарилзамещенные тетрагидробензазепины и их применение для блокировки обратного захвата норэпинефрина, допамина и серотонина |
| RU2309944C1 (ru) * | 2006-04-12 | 2007-11-10 | Общество с ограниченной ответственностью "ИФОХИМ" | Производные пара-метоксианилинов, повышающие стойкость углеводородных топлив к детонации, и топливная композиция (варианты) |
| AU2008215948A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of AD and related conditions |
| EP2121088B1 (en) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| EP2146722A4 (en) | 2007-05-10 | 2011-08-03 | Amr Technology Inc | ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND THEIR USE FOR BLOCKING THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE |
| CN101945853B (zh) | 2007-12-21 | 2014-08-20 | 配体药物公司 | 选择性雄激素受体调节剂(sarm)及其应用 |
| WO2009128057A2 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
| TWI530489B (zh) | 2011-03-22 | 2016-04-21 | 必治妥美雅史谷比公司 | 雙（氟烷基）－１，４－苯二氮呯酮化合物 |
| TWI614238B (zh) * | 2012-09-21 | 2018-02-11 | 必治妥美雅史谷比公司 | 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥 |
| JP2015529253A (ja) * | 2012-09-21 | 2015-10-05 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｎｏｔｃｈ阻害剤としてのフルオロアルキルおよびフルオロシクロアルキル１，４−ベンゾジアゼピノン化合物 |
| WO2014047370A1 (en) * | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Fluoroalkyl dibenzodiazepinone compounds |
| US9242941B2 (en) | 2012-09-21 | 2016-01-26 | Bristol-Myers Squibb Company | Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds |
| US9273075B2 (en) | 2012-09-21 | 2016-03-01 | Bristol-Myers Squibb Company | Prodrugs of 1,4-benzodiazepinone compounds |
| US9133139B2 (en) | 2012-09-21 | 2015-09-15 | Bristol-Myers Squibb Company | Fluoroalkyl-1,4-benzodiazepinone compounds |
| WO2014047393A1 (en) * | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors |
| US9187434B2 (en) | 2012-09-21 | 2015-11-17 | Bristol-Myers Squibb Company | Substituted 1,5-benzodiazepinones compounds |
| EP2897960B1 (en) | 2012-09-21 | 2016-08-03 | Bristol-Myers Squibb Company | Tricyclic heterocyclic compounds as notch inhibitors |
| EP2981267A1 (en) | 2013-04-04 | 2016-02-10 | Bristol-Myers Squibb Company | Combination therapy for the treatment of proliferative diseases |
| WO2015108988A2 (en) | 2014-01-17 | 2015-07-23 | Ligand Pharmaceuticals, Inc. | Methods and compositions for modulating hormone levels |
| WO2019099532A1 (en) | 2017-11-14 | 2019-05-23 | Northwestern University | Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin |
| KR102852740B1 (ko) | 2018-02-02 | 2025-08-29 | 알렉스자 파마스티칼즈, 인크. | 전기적 응축 에어로졸 디바이스 |
| MX2020012253A (es) | 2018-05-15 | 2021-01-29 | Ayala Pharmaceuticals Inc | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiazepinona para el tratamiento del carcinoma quistico adenoide. |
| SG11202011589WA (en) * | 2018-05-24 | 2020-12-30 | Ayala Pharmaceuticals Inc | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and immunotherapeutics and methods of use thereof |
| WO2020214834A1 (en) | 2019-04-19 | 2020-10-22 | Ligand Pharmaceuticals Inc. | Crystalline forms and methods of producing crystalline forms of a compound |
| CA3227665A1 (en) | 2021-08-02 | 2023-02-09 | Wassilios Grammenos | (3-pirydyl)-quinazoline |
| MX2024001592A (es) | 2021-08-02 | 2024-02-15 | Basf Se | (3-quinolil)-quinazolina. |
| EP4619394A1 (en) | 2022-11-16 | 2025-09-24 | Basf Se | Substituted tetrahydrobenzodiazepine as fungicides |
| CN120202195A (zh) | 2022-11-16 | 2025-06-24 | 巴斯夫欧洲公司 | 作为杀真菌剂的取代的苯并二氮杂䓬类 |
| EP4619393A1 (en) | 2022-11-16 | 2025-09-24 | Basf Se | Substituted benzodiazepines as fungicides |
| CN120957986A (zh) | 2023-03-17 | 2025-11-14 | 巴斯夫欧洲公司 | 用于对抗植物病原性真菌的取代的吡啶基/吡嗪基二氢苯并硫氮杂䓬化合物 |
| WO2025078181A1 (en) | 2023-10-09 | 2025-04-17 | Basf Se | Fungicidal mixture comprising substituted pyridines |
| WO2025078183A1 (en) | 2023-10-09 | 2025-04-17 | Basf Se | Fungicidal mixture comprising substituted quinazolyl quinolines |
Family Cites Families (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3651023A (en) * | 1968-07-02 | 1972-03-21 | Stamicarbon | Preparation of polyamides with special properties |
| FR2630440B1 (fr) | 1988-04-25 | 1991-09-20 | Jouveinal Sa | Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique |
| ATE119040T1 (de) | 1989-08-04 | 1995-03-15 | Merck Sharp & Dohme | Zentrale cholecystokinin-antagonisten zur behandlung von psychiatrischen krankheiten. |
| CA2026856A1 (en) | 1989-10-05 | 1991-04-06 | Mark G. Bock | 3-substituted-1,4-benzodiazepines useful as oxytocin |
| CA2032427A1 (en) | 1989-12-18 | 1991-06-19 | Mark G. Bock | Benzodiazepines analogs |
| GB9107368D0 (en) | 1991-04-08 | 1991-05-22 | Smithkline Beecham Plc | Novel compounds |
| FR2681962B1 (fr) * | 1991-09-30 | 1993-12-24 | Sgs Thomson Microelectronics Sa | Procede et circuit de traitement de donnees par transformee cosinus. |
| DK0652871T3 (da) | 1992-07-29 | 2001-12-03 | Merck Sharp & Dohme | Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linning |
| US5283241A (en) | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
| AU689762B2 (en) | 1992-12-21 | 1998-04-09 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| MX9308016A (es) | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
| AU6909194A (en) | 1993-05-14 | 1994-12-12 | Board Of Regents, The University Of Texas System | Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole |
| WO1994029273A1 (en) | 1993-06-09 | 1994-12-22 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5602156A (en) | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
| US5545735A (en) | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
| US5332359A (en) * | 1993-10-12 | 1994-07-26 | United Technologies Corporation | Stator assembly for a rotary machine having a centrifugal on impeller and volute |
| US5426185A (en) | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
| US5770573A (en) | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| US5763437A (en) | 1994-07-29 | 1998-06-09 | Fujisawa Pharmaceutical Co., Ltd. | Benzodiazepine derivatives |
| US5661161A (en) | 1994-09-29 | 1997-08-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JPH11505509A (ja) | 1994-12-09 | 1999-05-21 | スミスクライン・ビーチャム・コーポレイション | 二環式フィブリノーゲン拮抗薬 |
| EP0799189A4 (en) | 1994-12-13 | 1999-03-17 | Smithkline Beecham Corp | BICYCLIC FIBRINOGENIC ANTAGONISTS |
| US5639746A (en) | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
| US5856326A (en) | 1995-03-29 | 1999-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5578629A (en) | 1995-03-29 | 1996-11-26 | Merck & Co., Inc. | Benzamide-containing inhibitors of farnesyl-protein transferase |
| GB9507799D0 (en) | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
| US5710171A (en) | 1995-05-24 | 1998-01-20 | Merck & Co., Inc. | Bisphenyl inhibitors of farnesyl-protein transferase |
| DE69533991T2 (de) | 1995-05-29 | 2006-04-13 | Pfizer Inc. | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren |
| US5756528A (en) | 1995-06-06 | 1998-05-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JPH09188631A (ja) * | 1995-09-08 | 1997-07-22 | Kanebo Ltd | Ｆａｓリガンド可溶化抑制薬 |
| WO1997009066A1 (en) * | 1995-09-08 | 1997-03-13 | Kanebo, Ltd. | Fas LIGAND SOLUBILIZATION INHIBITOR |
| EP0761680A3 (en) | 1995-09-12 | 1999-05-06 | Ono Pharmaceutical Co., Ltd. | Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity |
| AU7139996A (en) | 1995-10-05 | 1997-04-28 | Chiroscience Limited | Mercaptoamide derivatives and their therapeutic use |
| JP2000500761A (ja) | 1995-11-23 | 2000-01-25 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
| JP2000504014A (ja) | 1996-01-30 | 2000-04-04 | メルク エンド カンパニー インコーポレーテッド | ファルネシル―タンパク質転移酵素の阻害剤 |
| JP2000507587A (ja) | 1996-04-03 | 2000-06-20 | メルク エンド カンパニー インコーポレーテッド | ファルネシルタンパク質トランスフェラーゼ阻害剤 |
| US5919785A (en) | 1996-04-03 | 1999-07-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5891889A (en) | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5965578A (en) | 1996-04-03 | 1999-10-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5869682A (en) | 1996-04-03 | 1999-02-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| WO1997036877A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5859012A (en) | 1996-04-03 | 1999-01-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5885995A (en) | 1996-04-03 | 1999-03-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| AU715603B2 (en) | 1996-04-03 | 2000-02-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5852010A (en) * | 1996-04-03 | 1998-12-22 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| WO1997038664A2 (en) | 1996-04-18 | 1997-10-23 | Merck & Co., Inc. | A method of treating cancer |
| AU3215197A (en) | 1996-05-30 | 1998-01-05 | Merck & Co., Inc. | A method of treating cancer |
| US5703129A (en) | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
| WO1998016523A2 (en) | 1996-10-11 | 1998-04-23 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| PL323130A1 (en) | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
| IL129477A0 (en) | 1996-11-22 | 2000-02-29 | Elan Pharm Inc | N-(aryl/heteroaryl)amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| ATE296797T1 (de) | 1996-11-22 | 2005-06-15 | Elan Pharm Inc | N-(aryl/heteroaryl/alkylacetyl) amino saüre amide,pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese |
| JP2001508408A (ja) | 1996-11-22 | 2001-06-26 | エラン・ファーマシューティカルズ・インコーポレイテッド | Ｎ―（アリール／ヘテロアリール）アミノ酸エステル、医薬組成物およびベータ―アミロイドペプチドの放出および／またはその合成を阻害する方法 |
| EP0951464B1 (en) | 1996-11-22 | 2005-05-11 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| SI0951466T1 (sl) * | 1996-12-23 | 2009-10-31 | Elan Pharm Inc | Cikloalkili, laktami, laktoni in sorodne spojine, farmacevtske zmesi, ki jih vsebujejo, in metode inhibicije sproščanja beta-amiloidnega peptida in/ali njegove sinteze z uporabo takih spojin |
| EP1003374A1 (en) | 1996-12-30 | 2000-05-31 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| EP0968206B8 (en) | 1997-02-19 | 2007-01-24 | Berlex, Inc. | N-heterocyclic derivatives as nos inhibitors |
| WO1998041510A1 (en) | 1997-03-14 | 1998-09-24 | Shionogi & Co., Ltd. | Novel benzolactam derivatives and medicinal compositions comprising the same |
| US5985900A (en) | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| EP0973396A4 (en) | 1997-04-07 | 2001-02-07 | Merck & Co Inc | METHOD FOR TREATING CANCER |
| DE19717472A1 (de) | 1997-04-25 | 1998-10-29 | Suban Ag | Verfahren und Vorrichtung zum Profilbiegen mit modularen Biegestationen |
| US6060038A (en) | 1997-05-15 | 2000-05-09 | Merck & Co., Inc. | Radiolabeled farnesyl-protein transferase inhibitors |
| DE19726427A1 (de) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| GB9715030D0 (en) | 1997-07-18 | 1997-09-24 | British Biotech Pharm | Metalloproteinase inhibitors |
| JP2001515842A (ja) | 1997-08-11 | 2001-09-25 | シーオーアール セラピューティクス インコーポレイテッド | 選択的Ｘａ因子阻害剤 |
| CA2299612A1 (en) | 1997-08-11 | 1999-02-18 | Cor Therapeutics, Inc. | Selective factor xa inhibitors containing a fused azepinone structure |
| AU735366B2 (en) | 1997-09-29 | 2001-07-05 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
| US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| JP2003521438A (ja) | 1997-12-22 | 2003-07-15 | エラン ファーマシューティカルズ，インコーポレイテッド | 多環式α−アミノ−ε−カプロラクタムおよび関連化合物 |
| CA2320694C (en) | 1998-02-20 | 2005-07-12 | Deep Video Imaging Limited | A multi-layer display and a method for displaying images on such a display |
| WO1999067219A1 (en) | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| AU5204799A (en) | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| CA2325389A1 (en) | 1998-06-22 | 1999-12-29 | James E. Audia | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| WO1999066934A1 (en) | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| WO2000002903A1 (en) | 1998-07-10 | 2000-01-20 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
| HRP990246A2 (en) * | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| NZ525513A (en) * | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
| CA2346099A1 (en) * | 1998-11-12 | 2000-05-18 | Dupont Pharmaceuticals Company | Use of radioligands to screen inhibitors of amyloid-beta peptide production |
| CN1636011A (zh) | 1998-12-24 | 2005-07-06 | 杜邦药品公司 | 作为Aβ蛋白产生抑制剂的琥珀酰氨基苯并二氮杂䓬 |
| AU2001239791A1 (en) | 2000-02-17 | 2001-08-27 | Du Pont Pharmaceuticals Company | Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production |
| AU783857B2 (en) * | 2000-06-01 | 2005-12-15 | Bristol-Myers Squibb Pharma Company | Lactams substituted by cyclic succinates as inhibitors of a beta protein production |
| CA2674915C (en) | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
-
1999
- 1999-12-23 CN CNA998147729A patent/CN1636011A/zh active Pending
- 1999-12-23 BR BR9917082-5A patent/BR9917082A/pt not_active IP Right Cessation
- 1999-12-23 WO PCT/US1999/030815 patent/WO2000038618A2/en not_active Ceased
- 1999-12-23 EP EP99964322A patent/EP1313426A4/en not_active Withdrawn
- 1999-12-23 JP JP2000590572A patent/JP4615727B2/ja not_active Expired - Lifetime
- 1999-12-23 CA CA002347671A patent/CA2347671A1/en not_active Abandoned
- 1999-12-23 AU AU20592/00A patent/AU778005B2/en not_active Ceased
- 1999-12-23 IL IL14281699A patent/IL142816A0/xx unknown
-
2000
- 2000-02-17 US US09/505,788 patent/US7053084B1/en not_active Expired - Lifetime
-
2001
- 2001-06-15 NO NO20012984A patent/NO20012984D0/no not_active Application Discontinuation
-
2005
- 2005-09-19 US US11/230,203 patent/US7304049B2/en not_active Expired - Lifetime
-
2006
- 2006-01-13 US US11/331,791 patent/US7456172B2/en not_active Expired - Fee Related
-
2008
- 2008-03-10 US US12/045,126 patent/US20080171735A1/en not_active Abandoned
- 2008-04-02 US US12/061,227 patent/US7718795B2/en not_active Expired - Fee Related
- 2008-10-20 US US12/254,431 patent/US20090069293A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL142816A0 (en) | 2002-03-10 |
| EP1313426A2 (en) | 2003-05-28 |
| JP4615727B2 (ja) | 2011-01-19 |
| WO2000038618A2 (en) | 2000-07-06 |
| JP2003523932A (ja) | 2003-08-12 |
| US20080171735A1 (en) | 2008-07-17 |
| WO2000038618A3 (en) | 2003-04-03 |
| AU2059200A (en) | 2000-07-31 |
| BR9917082A (pt) | 2001-11-06 |
| CN1636011A (zh) | 2005-07-06 |
| US20060025407A1 (en) | 2006-02-02 |
| US20090069293A1 (en) | 2009-03-12 |
| US7053084B1 (en) | 2006-05-30 |
| AU778005B2 (en) | 2004-11-11 |
| NO20012984L (no) | 2001-06-15 |
| US7304049B2 (en) | 2007-12-04 |
| US20080207602A1 (en) | 2008-08-28 |
| EP1313426A4 (en) | 2003-05-28 |
| US20060122169A1 (en) | 2006-06-08 |
| US7718795B2 (en) | 2010-05-18 |
| CA2347671A1 (en) | 2000-07-06 |
| US7456172B2 (en) | 2008-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012984D0 (no) | Succinoylamino benzodiazepiner som inhibitorer av AB proteinproduksjon | |
| NO20004219L (no) | Inhibitorer av fosfolipaseenzymer | |
| NO20004220L (no) | Inhibitorer av fosfolipaseenzymer | |
| ID27092A (id) | Pembuatan ftalat anhidrida | |
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| NO20010534L (no) | Amidderivater nyttige som inhibitorer av produksjon av cytokiner | |
| AR028253A1 (es) | Inhibidores de la glucogeno fosforilasa | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| NO992165L (no) | Forbedret fremstilling av isoprenoider | |
| PT1086076E (pt) | Inibidores de sulfonamida de aspartil protease | |
| DK1185529T3 (da) | Pyrazolbenzodiazepiner som CDK2-inhibitorer | |
| ID30233A (id) | Antibiotika ketolida | |
| NO20004550D0 (no) | Enzyminhibitorer | |
| NO20016034D0 (no) | Inhibitorer av aspartylprotease | |
| ID26990A (id) | Metode pembuatan dimetilnaftalena | |
| NO20011083L (no) | Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH | |
| IT1298535B1 (it) | Procedimento per la produzione di gamma-butirrolattone | |
| NO20001198D0 (no) | Pyrrolopyrrolondervater som inhibitorer av neutrofil elastase | |
| IT1298096B1 (it) | Procedimento per la produzione di gamma-butirrolattone | |
| DE69908614D1 (de) | Herstellung von n-substituierten-hydroxycycloalkylamin-derivaten | |
| ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
| NO20005301D0 (no) | Pyrrolidiner som inhibitorer av neuraminidaser | |
| NO20001200D0 (no) | Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase | |
| NO20004664D0 (no) | FremgangsmÕte for fremstilling av HIV proteaseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |